Simultaneous quantification of 26 NAD-related metabolites in plasma, blood, and liver tissue using UHPLC-MS/MS

Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice

Jun Yoshino, Kathryn F. Mills, Myeong Jin Yoon et al. · Cell Metabolism · 2011 · 1.3K citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice

Kathryn F. Mills, Shohei Yoshida, Liana R. Stein et al. · Cell Metabolism · 2016 · 896 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Juliana Camacho-Pereira, Mariana G. Tarragó, Claudia C.S. Chini et al. · Cell Metabolism · 2016 · 867 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Nicotinamide riboside is uniquely and orally bioavailable in mice and humans

Samuel A.J. Trammell, Mark S. Schmidt, Benjamin J. Weidemann et al. · Nature Communications · 2016 · 708 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Quantitative Analysis of NAD Synthesis-Breakdown Fluxes

Ling Liu, Xiaoyang Su, William J. Quinn et al. · Cell Metabolism · 2018 · 575 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14